We assumed that the Rb1 gene activation detected in PDGFRα-depleted GBM CSC clones would promote anti-proliferative and anti-apoptotic effects and along with Stat3 might induce the molecular profile change observed in differentiated PDGFRα-depleted GBM CSC. This evidence concerns the gene RB1 and glioblastoma.